Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating adjunctive KarXT (xanomeline/trospium) for mania in adults with Bipolar I Disorder on lithium, valproate, or lamotrigine. Recruitment i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Mania

Drugs mentioned

• KarXT (xanomeline-trospium)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Mania, Bipolar Disorder | Phase 3 | Status: RECRUITING